Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine Feb/03/2022 60 0
mRNA-1273 Emergency use authorization Experimental Vaccine Feb/03/2022 25 0
Mesenchymal stem cells Potential treatment - clinical evidence Experimental Other treatment Dec/24/2021 48 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jul/12/2021 87 22
GC376 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021 12 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Anacardic acid Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021 2 0
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021 26 15
Epigallocatechin Gallate Potential treatment - pre-clinical evidence Natural product Antiviral Apr/08/2021 11 0
Teicoplanin Potential treatment - pre-clinical evidence Experimental Antiviral Mar/06/2021 2 1